A study to determine the incidence of Ki67 ≥ 20% in patients with ER+ HER2- G2 node-negative stage IIA breast cancer
Keyword(s): breast cancer; Ki67; CDK4/6 inhibitor; immunohistochemistry; qRT-PCR
Year: 2026
Interested in this project?
If you would like to learn more about this project or explore a potential collaboration with the research team,
please contact us (The project title will be quoted automatically). We will forward your enquiry to the project lead to explore potential
opportunities for collaboration.
